Puqi Pharma IPO Prospectus Expires on July 21; Filed Six Months Earlier

According to Zhitong Finance & Economics, Puqi Pharma (北京普祺医药科技股份有限公司) had its Hong Kong IPO prospectus expire on July 21, 2026, six months after submission on January 21, 2026. China Securities and Minyin Capital served as joint sponsors for the offering.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments